Want to see KROS full AI Analyst Report?
Keros Therapeutics (KROS) Ownership - Who Owns Keros Therapeutics?
Keros Therapeutics (KROS) Ownership Overview
- 5.14% Insiders
- 20.94% Mutual Funds
- 0.27% Other Institutional Investors
- 14.79% ETFs
- 58.87% Public Companies and Individual Investors
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 35.99% of the company’s stock is owned by Institutional Investors, 5.14% is owned by Insiders, and 58.87% is owned by Public Companies and Individual Investors.
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 21.20% of the company’s stock is owned by Institutional Investors, 5.14% is owned by Insiders, and 14.79% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 19, 2026 | Lorena Raquel Lerner | $36,715 | |
| Aug 19, 2026 | Annita Tanini | $12,595 | |
| Feb 19, 2026 | Jasbir Seehra | $113,433 | |
| Feb 19, 2026 | Keith Regnante | $77,483 |
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 999,125 | Institution | 5.04% | 11,030,340 |
| Vanguard | 998,864 | Institution | 5.04% | 11,027,459 |
| Vanguard Index Funds | 816,170 | Institution | 4.12% | 9,010,517 |
| Blackrock Funds | 499,706 | Institution | 2.52% | 5,516,754 |
| Federated Hermes Mdt Series | 498,518 | Institution | 2.51% | 5,503,639 |
| Jasbir Seehra | 440,708 | Insider | 2.22% | 4,865,416 |
| Tiaa-cref Funds | 283,365 | Institution | 1.43% | 3,128,350 |
| Julius Knowles | 263,238 | Insider | 1.33% | 2,906,148 |
| Dfa | 261,970 | Institution | 1.32% | 2,892,149 |
| Vanguard Horizon Funds | 258,657 | Institution | 1.30% | 2,855,573 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 816,170 | Institution | 4.12% | 9,010,517 |
| Blackrock Funds | 499,706 | Institution | 2.52% | 5,516,754 |
| Federated Hermes Mdt Series | 498,518 | Institution | 2.51% | 5,503,639 |
| Tiaa-cref Funds | 283,365 | Institution | 1.43% | 3,128,350 |
| Vanguard Horizon Funds | 258,657 | Institution | 1.30% | 2,855,573 |
| Fidelity Salem Street Trust | 228,945 | Institution | 1.15% | 2,527,553 |
| Dfa Investment Dimensions Group Inc | 211,205 | Institution | 1.07% | 2,331,703 |
| Vanguard Explorer Fund | 171,150 | Institution | 0.86% | 1,889,496 |
| Bridge Builder Trust | 162,294 | Institution | 0.82% | 1,791,726 |
| Fidelity Concord Street Trust | 151,513 | Institution | 0.76% | 1,672,704 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 595,316 | Institution | 3.00% | 6,786,602 |
| iShares | 466,289 | Institution | 2.35% | 5,297,043 |
| Vanguard | 227,695 | Institution | 1.15% | 2,595,723 |
| iShares | 173,481 | Institution | 0.87% | 1,970,744 |
| DFA | 162,827 | Institution | 0.82% | 1,849,715 |
| iShares | 142,038 | Institution | 0.72% | 1,568,100 |
| iShares | 108,092 | Institution | 0.55% | 1,227,925 |
| Vanguard | 107,845 | Institution | 0.54% | 1,229,433 |
| Bridgeway | 106,517 | Institution | 0.54% | 1,210,033 |
| Schwab | 104,339 | Institution | 0.53% | 1,185,291 |
FAQ
Who Owns Keros Therapeutics (KROS)?
According to the latest TipRanks data, approximately 0.27% of the company's stock is held by institutional investors, 5.14% is held by insiders, and 58.87% is held by retail investors.
What percentage of Keros Therapeutics (KROS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.27% of Keros Therapeutics (KROS) stock is held by institutional investors.
What percentage of Keros Therapeutics (KROS) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.87% of Keros Therapeutics (KROS) stock is held by retail investors.
Who owns the most shares of Keros Therapeutics (KROS)?
iShares owns the most shares of Keros Therapeutics (KROS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.